Jenin 150 mg (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Korea PMG Pharmaceutical Co., Ltd.
MFDS item code 201400259 · Approved 2014.01.21
This product's status changed to Expired on 2024.01.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers and esophagitis), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
This medication is effective for conditions such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used to prevent Mendelson's syndrome before anesthesia, and for gastric and duodenal ulcers after surgery and due to NSAID administration. It aids in improving gastric mucosal lesions due to acute gastritis, chronic gastritis acute exacerbation, and upper gastrointestinal bleeding. It is also effective for alleviating hyperacidity, heartburn, and sour stomach symptoms. This medication is used to treat various gastric-related diseases and symptoms and to improve symptoms.
For ranitidine, administer 150 mg orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg orally twice daily or 300 mg once daily at bedtime. A higher treatment rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for combination therapy to prevent ulcers caused by administration of nonsteroidal anti-inflammatory drugs or the development of gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by administration of nonsteroidal anti-inflammatory drugs, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease: Administer 150 mg twice daily for 8 weeks or 300 mg once daily before bedtime. For patients with severe gastroesophageal reflux disease, the dose may be increased to 150 mg 4 times daily. Zollinger-Ellison syndrome: Initiate treatment with 150 mg 3 times daily and increase the dose as needed. For severe disease, up to 6 g per day may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration and administer 150 mg twice daily. Pre-anesthetic medication (prevention of Mendelson syndrome): Administer 150 mg 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg once daily at bedtime. For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
For patients 8 〜 18 years of age, 150 mg per dose (2 mg per kg of body weight) may be administered up to twice daily. For patients 12 years of age and older, administer 75 mg orally twice daily (oral solution only).
This medication should not be used in patients with a history of allergic reaction to any ingredient of this medication. It should also not be administered to patients with a history of acute porphyria as it may trigger acute porphyric attacks. Additionally, this medication contains lactose and should not be given to patients with genetic issues such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. Patients with impaired kidney function may have elevated serum concentrations of this medication and should reduce the dose or increase the dosing interval; those with impaired liver function should also use this medication with caution. Patients with a history of drug allergies, the elderly, and those taking non-steroidal anti-inflammatory drugs should be administered this medication carefully. Especially, since it can mask symptoms of gastric cancer, it is essential for patients with gastric ulcers or middle-aged patients with changes in recent indigestion symptoms to verify that it is not a malignant disease before use. Patients with gastric and duodenal ulcers caused by Helicobacter pylori need eradication therapy. This medication may rarely cause severe allergic reactions such as anaphylaxis shock, so if abnormal symptoms occur during administration, treatment should be discontinued immediately. If hypersensitivity reactions occur such as hives, rash, bronchospasm, or hypotension, administration should be stopped. Various side effects like blood cell count decrease, liver dysfunction, cardiac rhythm abnormalities, digestive disturbances, and neurological symptoms are rarely reported, and if symptoms arise, consult with a healthcare professional promptly. During treatment, abnormalities should be checked through blood tests, liver function tests, and kidney function tests. The elderly and patients with chronic diseases may have increased risk of pneumonia, so caution is required. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may affect the absorption or metabolism of other drugs; thus, inform healthcare professionals of any concurrently administered medications. Particularly, when combined with anticoagulants like warfarin, the risk of bleeding may increase, necessitating periodic testing. Women who are pregnant or may become pregnant, as well as nursing women, should use this medication with caution, and it should only be given when the benefits outweigh the risks. Safety in children has not been fully established, so caution is necessary. The elderly may require dose adjustments due to potential drug accumulation from decreased kidney function. This medication may yield false positive results in some tests when using test strip methods, so accurate testing methods should be employed. While special toxicity symptoms from overdose are rare, symptomatic treatment such as vomiting or gastric lavage may be needed, and in severe cases, hemodialysis may be beneficial. Store this medication out of reach of children and do not transfer to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container that can block light, in a dry place at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's efficacy for a longer period.
White round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Korea PMG Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.